BAM
FPRX

Blueshift Asset Management’s Five Prime Therapeutics, Inc. FPRX Stock Holding History

Blueshift Asset Management’s Portfolio FPRX Stock Details FPRX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2021
Q2 		– Sell
-8,576
Closed -$323K – 1280
2021
Q1 		$323K Buy
+8,576
New +$214K 0.03% 613

Blueshift Asset Management's FPRX Position: Q2 2021 in Review

Blueshift Asset Management sold out of Five Prime Therapeutics, Inc. (FPRX) in Q2 2021, closing a stake of 8,576 shares — an estimated $323K sold.

Blueshift Asset Management first reported a position in FPRX in Q1 2021 and held it in 1 quarter. The position peaked at $323K in Q1 2021. 0 funds tracked by Wall St. Rank hold FPRX as of Q2 2021.

  • Blueshift Asset Management reported no remaining Five Prime Therapeutics, Inc. position as of Q2 2021 after selling out during the quarter.
  • Blueshift Asset Management sold 8,576 Five Prime Therapeutics, Inc. shares in Q2 2021, an estimated $323K.
  • Blueshift Asset Management first reported a position in Five Prime Therapeutics, Inc. in Q1 2021 and held it in 1 quarter.
  • Blueshift Asset Management's Five Prime Therapeutics, Inc. position peaked at $323K in Q1 2021.
  • 0 funds tracked by Wall St. Rank held Five Prime Therapeutics, Inc. as of Q2 2021.

Based on Blueshift Asset Management's 13F filing for Q2 2021, filed 13 Aug 2021.